|
American Diabetes Association. Implications of the United
Kingdom Prospective Diabetes Study. Diabetes Care 1999; 22(suppl
1): S27-S31.( RB1) |
|
American Diabetes Association.Diabetic Nephropathy. Diabetes
Care 1999; 22 (suppl 1): S66-S69. (RB2) |
|
Amoah E, Glickman JL, Malchoff CD et al. Clinical identification
of non diabetic renal disease in diabetic patients with type 1 and
type 2 disease presenting with renal dysfunction. Am J Nephrol
1988; 8: 204-11.(RB3) |
|
Annonymus. Summary of the second report of the National
Cholesterol Education Program (NCEP)Expert Panel on Detection,
Evaluation, and Treatment of High Blood Cholesterol in Adults
(adult Treatment Panel II) JAMA 1993; 269: 3015-3023 (RB51) |
|
Bakris GL, Copley
JB, Vicknair N, Sadler R, Leurgans S. Calcium channel blockers
versus other antihypertensive therapies on progression of NIDDM
associated nephropathy. Kidney Int 1996; 50:1641-50. (RB4) |
|
Canadian Medical Association.1998 clinical practice guidelines
for the management of diabetes in Canada. CMAJ 1998; 159 (8
suppl). (RB5) |
|
Chalmers J et al.
WHO-ISH Hypertension Guidelines Committee. 1999 World Health
Organization - International Society of Hypertension Guidelines
for the Management of Hypertension. J Hypertens, 1999,
17:151-185. (RB6) |
|
Cooper ME.
Pathogenesis, prevention, and treatment of diabetic nephropathy.
Lancet 1998; 352: 213-19. (RB7) |
|
Corchado Y, Sanchez Mata P, Duarte C et al. Estudio de
microalbuminuria en pacientes diabéticos tipo 2. Atención
Primaria 1991; 8: 886-90 (RB8) |
|
Desktop guide to Type 2 diabetes mellitus. European Diabetes
Policy Group 1999. Diabet Med. 1999; 16: 716-30. (RB9) |
|
Diamond JM. Human evolution: Diabetes running wild. Nature 1992;
357: 362-3(RB10) |
|
Esmatges E,
Castell C, Gonzalez A T. Epidemiology of renal involvement in
type 2 diabetics in Catalonia. Diabetes Res Clin Pract 1996; 32:
157-63(RB11) |
|
Estudio Diamante.
Renal involvement in type 1 diabetes in Spain. Diabetes Res Clin
Pract 1997; 38: 129-37(RB12) |
|
Gaede P, Vedel P,
Parving HH Pedersen O. Intensified multifactorial intervention
in patients with type 2 diabetes mellitus and microalbuminuria:
the Steno type 2 randomised study. Lancet 1999; 353:
617-22.(RB13) |
|
Gall M, Rossing
P, Skott P et al. Prevalence of micro and macroalbuminuria,
arterial hypertension, retinopathy and large vessel disease in
European type 2 diabetic patients.Diabetologia 1991; 34:
655-661(RB14) |
|
Gomez FJ, Luño J, Garcia S, Valderrábano F. ¿Por
qué es necesaria la remisión precoz a la consulta
del nefrólogo de los pacientes con nefropatía diabética?
Atención Primaria 1999; 23:503-4(RB15) |
|
Gonzalez, M.T.,
Castell C., Esmatjes E. Et al. Insuficiencia renal secundaria a
nefropatía diabética. Revisión de las
características de los pacientes diabéticos que
iniciaron diálisis en Cataluña en 1994. Rev. Clin.
Esp. 1999; 199: 8-12.(RB16) |
|
Guía para el tratamiento de la diabetes tipo 2 en la
Atención Primaria (3ª ed). Ed. Gedaps. 2000. (RB17) |
|
Ismail N, Becker
B, Strzelczyk P, Ritz E. Renal disease and hypertension in
non-insulin-dependent diabetes mellitus. Kidney International
1999; 55: 1-28. (RB18) |
|
Jameel N, Pughja
A, Mitchell B, Stern M. Dietary protein intake in not correlated
with clinical proteinuria in NIDDM. Diabetes Care 1992; 15:
178-83 (RB19) |
|
Kasiske BL, Kalil
RSN, Ma JZ, Liao M, Keane WF. Effect of Antihypertensive Therapy
on the Kidney in Patients with Diabetes: A Meta-Regression
Analysis. Annals of Internal Medicine.1993; 118: 129-138. (RB20) |
|
Lazarus J.M., Brenner B M, Insuficiencia renal crónica.
En: Harrison, Principios de Medicina Interna (14ª ed. Esp.)
Madrid: McGraw-Hill.Interamericana. 1998; 1720-1727. (RB21) |
|
Lewis EJ,
Hunsicker LG, Bain RP, Rodhe RD. The effect of
angiotensin-converting-enzyme inhibition on diabetic
nephropathy. The Collaborative Study Group. N Engl J Med 1993;
329: 1456-62. (RB22) |
|
Lippert J, Ritz
E, Schwarzbeck A, Schneider P. The rising tide of endstage
failure from diabetic nephropaty type 2: an epidemiological
analysis. Nephrol Dial Transplant 1995; 10: 462-7.(RB23) |
|
Lovell HG. Are angiotensin converting enzyme inhibitors useful
for normotensive diabetic patients with microalbuminuria?.
Cochrane Database of Systematic Reviews. Issue 2, 1999.(RB24) |
|
Mata M. Microalbuminuria y diabetes. FMC 1994; 1: 104-11 (RB25) |
|
Mogensen CE,
Christensen CK, Vittinghus E: The stages in diabetic renal
disease: With emphasis on the stage of incipient diabetic
nephropaty. Diabetes 1983; 32 (suppl 2): 64-78. (RB26) |
|
Mogensen CE, Keane WF, Bennet PH, Jerums G, Parving HH Passa P.
Prevención de la nefropatía diabética con
especial referencia a la microalbuminuria. Lancet (ed. Esp.) 1996;
28:201-206. (RB27) |
|
Mogensen CE. Microalbuminuria: Un marcador de lesión orgánica.
London. Science Press 1994(RB28) |
|
Parving HH, Gall
MA, Skoit P. Prevalence and causes of albuminuria in
non-insulin-dependent diabetic patients. Kidney Int 1992; 41:
758-62 (RB29) |
|
Parving HH,
Tarnow L, Rossing P. Renal protection in diabetes-an emerging
role for calcium antagonists. Cardiology 1997; 88(suppl 3):
56-62.(RB30) |
|
Parving HH. Renoprotection in diabetes: genetic and non-genetic
risk factors and treatment. Diabetologia 1998; 41: 745-759. (RB31) |
|
Passa P. Diabetic nephropaty in the NIDDM patient on the
interface between diabetology and nephrology. What do we have to
improve? Nephrol Dial Transplant 1997; 12: 1316-7(RB32) |
|
Pedrini M, Levey
A, Lau J, Chalmers T, Wang P. The Effect of Dietary Protein
Restriction on the Progression of Diabetic and Nondiabetic Renal
Diseases: A Meta-Analysis. Ann Internn Med 1996; 124:
627-32(RB33) |
|
Pomerleau J,
Verdy M, Garrel D, Nadeau M. Effect of protein intake on
glycaemic control and renal function in type 2 diabetes
mellitus. Diabetologia 1993; 36: 829-34(RB34) |
|
Pommer W et al. There is a room for improvement of preterminal
care in diabetic patients with end-stage renal faillure: The
epidemiological evidence in Germany. Nephrol Dial Transplant 1997;
12: 1318-20 (RB35) |
|
Ramsay LE, Williams B, Johnston GD, MacGregor GA, Poston L,
Potter J, et al. British Hypertension Society guidelines for
hypertension management 1999: summary. BMJ 1999; 319:
630-635.(RB36) |
|
Ravid M, Lang R,
Rachmani R, Lishner M. Long-term Renoprotective Effect of
Angiotensin-converting Enzyme Inhibition in
Non-Insulin-dependent Diabetes Mellitus. Arch Intern Med 1996;
156: 286-289.(RB37) |
|
Ritz E, Koch M,
Fliser D, Schwenger V. How can We Improve Prognosis in Diabetic
Patients With End-Stage Renal Disease?. Diabetes Care 1999; 22:
B80-83.(RB38) |
|
Ritz E, Reinhold S. Nephropaty in Patients with Type 2 Diabetes
Mellitus. N Engl J Med 1999; 341: 1127-33(RB39) |
|
Ritz E, Rychlik
I, Locatelli F, Halimi S. End-Stage Renal Failure in Type 2
Diabetes: A Medical Catastrophe of Worlwide Dimensions. Am J
Kidney Dis. 1999; 34: 795-808.(RB40) |
|
Ritz E.
Nephropathy in type 2 diabetes. J Intern Med 1999; 245:
111-26.(RB41) |
|
Salvetti A,
Mattei P, Sudano I. Renal Protection and Antihypertensive Drugs.
Drugs 1999; 57: 665-693.(RB42) |
|
Scottish Intercollegiate Guidelines Network. Management of
Diabetic Renal Disease. Edimburgh 1997.(RB43) |
|
Sociedades Españolas de Diabetes, Endocrinología,
Medicina Familiar y Comunitaria y Nefrología. Documento de
consenso sobre pautas de detección y tratamiento de la
nefropatía diabética en España. Aten Primaria
1998; 21: 471-476.(RB44) |
|
Solanas JV, Soler JM, Ros A, Fos V, Vento D, Prósper M.
Validez de los métodos semicuantitativo de cribado de la
microalbuminuria en la diabetes mellitus. Aten Primaria 1998; 22:
631-635.(RB45) |
|
The EUCLID study
group. Randomised placebo-controlled trial of lisinopril in
normotensive patients with insulin-dependent diabetes and
normoalbuminuria or microalbuminuria. Lancet 1997; 349: 1787-92
(RB50) |
|
The Sixth Report
of the Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure. National
Institutes of Health (JNC-VI). Arch Intern Med 1997;
157:2413-2446.(RB46) |
|
Tight blood
pressure control and risk of macrovascular and microvascular
complications in type 2 diabetes: UKPDS 38. UK Prospective
Diabetes Study Group. BMJ 1998; 317: 703-13.(RB47) |
|
Toeller M, Buyken
A, Heitkamp G et al. Protein intake and urinary albumin
excretion rates in the EURODIAB IDDM Complications Study.
Diabetologia 1997; 40: 1219-26(RB48) |
|
Zmiron D,
Benhamon PY,Cordonier D et al. Diabetes mellitus prevalence
among dyalised patients in France (UREMIDIAB Study). Neprhol
Dial Transplant 1992; 7: 1092-7(RB49) |